Literature DB >> 22459331

Adherence to treatment is a complex and multifaceted issue that can substantially alter the outcome of chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.

Massimo Breccia, Fabio Efficace, Giuliana Alimena.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22459331     DOI： 10.1016/j.leukres.2012.02.032

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  3 in total

1.  How to report adherence to treatment as clinically relevant data-making a case of CML and TKI.

Authors:  Lucas Miyake Okumura
Journal:  Support Care Cancer       Date:  2017-07-11       Impact factor: 3.603

2.  Novel Humanitarian Aid Program: The Glivec International Patient Assistance Program-Lessons Learned From Providing Access to Breakthrough Targeted Oncology Treatment in Low- and Middle-Income Countries.

Authors:  Pat Garcia-Gonzalez; Paula Boultbee; David Epstein
Journal:  J Glob Oncol       Date:  2015-09-23

3.  Primary Localized Gastrointestinal Stromal Tumors: Medication Adherence and Prognosis According to Gender.

Authors:  Pan Ran; Juan Li; Xingye Wu; Hao Yang; Jun Zhang
Journal:  Patient Prefer Adherence       Date:  2022-08-12       Impact factor: 2.314
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.